Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARAGON: Irinotecan Bead + Irinotecan in Metastatic Colorectal Cancer
NCT00816777Phase 2Terminated
- Sponsor
- Generic Devices Consulting
- Start
- Dec 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of irinotecan in colorectal cancer (metastatic) (mCRC), sponsored by Generic Devices Consulting. Started Dec 2008; status: terminated.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00816777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00816777.